Milestone:   

2009 - Incorporation of Alseal, in Besançon - France
2009 - CE mark for HQS active valve
2009 - First clinical use of HQS active valve - Monaco
2010 - CE mark for pre-dilators
2010 - Successful trials - Bordeaux, Paris, Marseille
2010 - HQS active valve awarded at CX Vascular Symposium (London) innovating show case
2011 - CE mark for XCath
2011 - Setting-up export department - Trials - Italy, Netherland, Germany, ...
2011 - XCath awarded at CX Vascular Symposium (London) innovating show case
2012 - Trials - Sweden, UK, Hong-Kong, Switzerland, ...
2012 - Moving to new offices at Bioparc in Besançon - France
2012 - FDA 510(K) clearance for HQS active valve
2014 - FDA 510(K) clearance for XCath multi access

Dernières parutions :   

Vascular News #56, Nov. 2012
Vascular News #55, Sept. 2012